GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

MBIN · Mar 31, 2026

Merchants Bancorp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001104659-26-057107Bank
Sequential deposit growth25thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

-0.69% · CORE · VALID

Net-income growth60thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

16.30% · CORE · VALID

Interest-income growth20thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

-5.81% · CORE · VALID

Cash and equivalents0thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$83.2M · CORE · VALID

Sequential loan growth65thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

4.10% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History35 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
-6.41%
Current
-0.69%
Delta
5.73%
Earnings Growth Increased
Previous
-31.72%
Current
16.30%
Delta
48.02%
Interest Income Growth Increased
Previous
-7.82%
Current
-5.81%
Delta
2.01%
Liquidity Decreased
Previous
$212.2M
Current
$83.2M
Delta
-$129.0M
Loan Growth Decreased
Previous
4.15%
Current
4.10%
Delta
-0.05%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.